ECNP Summit on the future of CNS drug research in Europe 2011: report prepared for ECNP by David Nutt and Guy Goodwin.
نویسندگان
چکیده
In early March 2011 the European College of Neuropsy2. Enhance research. chopharmacology (ECNP) hosted a summit to consider the implications and consequences of the abrupt withdrawal of a number of major pharmaceutical companies from key areas of neuroscience research and development in brain disorders and psychopharmacology in particular. This paper presents the recommendations of the summit plus details of the background and analyses of the problem. It will be widely circulated within Europe and elsewhere.
منابع مشابه
Keynote Session marks official opening of 28 th ECNP Congress
E CNP President Guy Goodwin delivered a warm and informative welcome address for the 28th ECNP Congress in Amsterdam on Saturday evening, commenting: “The objective of ECNP is to advance the science of the brain, and most crucially to apply that science for promotion of better treatment and enhanced brain health. “We can achieve this by bringing people together: scientists, clinicians and indus...
متن کاملCognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report.
This is a report arising from an ECNP expert meeting. Recent studies have focussed on cognitive problems in manic-depressive illness and a few have addressed premorbid neuropsychological functioning. The results are not fully consistent but seem to point to a neurodegenerative model, rather than a neurodevelopmental one, for some cognitive domains. There is agreement that cognitive dysfunction ...
متن کاملConsensus Statement on European Brain Research: the need to expand brain research in Europe - 2015.
R. G. M. Morris, W. Oertel, W. Gaebel, G. M. Goodwin, A. Little, P. Montellano, M. Westphal, D. J. Nutt and M. Di Luca Federation of European Neuroscience Societies (FENS), Bruxelles, Belgium European Academy of Neurology (EAN), Vienna, Austria European Psychiatric Association (EPA), Strasburg, France European College of Neuropsychopharmacology (ECNP), Utrecht, The Netherlands European Federati...
متن کاملSpeaker 1: David Nutt, UK
My talk will focus on the use of the new ECNP nomenclature system to explain the mechanisms of actions of drugs for anxiety and insomnia so that prescribers have a better understanding of their modes of actions and adverse effects
متن کاملSpeaker 2: Pierre Blier, Canada
My talk will focus on the use of the new ECNP nomenclature system to explain the mechanisms of actions of drugs for anxiety and insomnia so that prescribers have a better understanding of their modes of actions and adverse effects
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
دوره 21 7 شماره
صفحات -
تاریخ انتشار 2011